Abstract:BACKGROUND:Gallbladder cancer (GBC) is the most prevalent and invasive biliary tract malignancy. As a GTPase-activating protein, Neurofibromin 1 (NF1) is a tumor suppressor that negatively regulates the RAS signaling pathway, and its abnormality leads to neurofibromatosis type 1 (NF-1) disease. However, the role of NF1 playing in GBC and the underlying molecular mechanism has not been defined yet.METHODS:A combination of NOZ and EH-GB1 cell lines as well as nude mice, were utilized in this study. mRNA expression and protein levels of NF1 and YAP1 were evaluated by quantitative real-time PCR (qRT-PCR), western blot (WB), and immunohistochemistry (IHC). In vitro and in vivo assays were performed to explore the biological effects of NF1 in NOZ and EH-GB1 cells via siRNA or lv-shRNA mediated knockdown. Direct interaction between NF1 and YAP1 was detected by confocal microscopy and co-immunoprecipitation (Co-IP), and further confirmed by GST pull-down assay and isothermal titration calorimetry assay (ITC). The stability of proteins was measured by western blot (WB) in the presence of cycloheximide.RESULTS:This study showed that a higher level of NF1 and YAP1 was found in GBC samples than in normal tissues and associated with worse prognoses. The NF1 knockdown impaired the proliferation and migration of NOZ in vivo and in vitro by downregulating YAP1 expression. Moreover, NF1 co-localized with YAP1 in NOZ and EH-GB1 cells, and the WW domains of YAP1 specifically recognized the PPQY motif of NF1. The structural modeling also indicated the hydrophobic interactions between YAP1 and NF1. On the other hand, YAP1 knockdown also impaired the proliferation of NOZ in vitro, phenocopying the effects of NF1 knockdown. Overexpression of YAP1 can partially rescue the impaired proliferation in NF1 stably knockdown cells. In mechanism, NF1 interacted with YAP1 and increased the stability of YAP1 by preventing ubiquitination.CONCLUSIONS:Our findings discovered a novel oncogenic function of NF1 by directly interacting with YAP1 protein and stabilizing YAP1 to protect it from proteasome degradation in NOZ cells. NF1 may serve as a potential therapeutic target in GBC.

NDR1 Functions As Tumor Suppressor in Glioblastoma by Phosphoralation of YAP

Nuclear Dbf2-related Kinase 1 functions as tumor suppressor in glioblastoma by phosphorylation of Yes-associated protein

Yap Promotes The Proliferation Of Neuroblastoma Cells Through Decreasing The Nuclear Location Of P27(Kip1) Mediated By Akt

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

FRK Inhibits Glioblastoma Progression Via Phosphorylating YAP and Inducing Its Ubiquitylation and Degradation by Siah1.

NTRK1 is a positive regulator of YAP oncogenic function

The Oncogenic Role of NF1 in Gallbladder Cancer Through Regulation of YAP1 Stability by Direct Interaction with YAP1.

Knockdown of NUSAP1 Inhibits Cell Proliferation and Invasion Through Down-Regulation of TOP2A in Human Glioblastoma

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Expression and Significance of Hippo/YAP Signaling in Glioma Progression.

NDRG4 is Downregulated in Glioblastoma and Inhibits Cell Proliferation.

Inhibitory effect of knocking-down Yes-associated protein for the growth of SNB19 glioma cells

Knockdown of Nupr1 Inhibits the Proliferation of Glioblastoma Cells Via Erk1/2, P38 Mapk and Caspase-3

Blockage of Glioma Cell Survival by Truncated TEAD-binding Domain of YAP.

N-Myc Downstream-Regulated Gene 2 (ndrg2) Inhibits Glioblastoma Cell Proliferation

Expression of Yap and Inhibitory Effect by Igf-1r Suppressor in Diffuse Large B-Cell Lymphoma

Β-Catenin-mediated YAP Signaling Promotes Human Glioma Growth

Lower Expression of Nrdp1 in Human Glioma Contributes Tumor Progression by Reducing Apoptosis.

YAP signaling is involved in WDR1-regulated proliferation and migration of non-small-cell lung cancer cells

Circadian Regulator NR1D2 Regulates Glioblastoma Cell Proliferation and Motility

BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling